30
Participants
Start Date
January 26, 2024
Primary Completion Date
June 1, 2026
Study Completion Date
October 1, 2026
Liraglutide Pen Injector [Saxenda]
A weight loss drug that can be taken at home. Liraglutide will be provided as an injectable pen that participants can inject in the stomach, thigh or upper arm. A member of the research team will give you instructions on how to inject liraglutide using the injectable pen and answer any questions.
Medication Diary
Participants will be asked to maintain a medication diary of each dose of liraglutide. A member of the research team will provide a copy of this diary for participants to complete. Participants will be asked to return this medication diary to research staff at each clinic visit.
RECRUITING
University of Chicago Medicine Comprehensive Cancer Center, Chicago
University of Chicago
OTHER